SGH
REGN icon

Sivik Global Healthcare’s Regeneron Pharmaceuticals REGN Stock Holding History

Sivik Global Healthcare’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.09M Hold
4,000
– – 2.35% 24
2026
Q1 		$3.09M Buy
+4,000
New +$3.06M 2.35% 24
2021
Q4 		– Sell
-160,000
Closed -$5.79M – 54
2021
Q3 		$5.79M Buy
+160,000
New +$99.3M 1.38% 29
2021
Q1 		– Sell
-20,000
Closed -$9.66M – 57
2020
Q4 		$9.66M Buy
20,000
+10,000
+100% +$5.4M 3.94% 3
2020
Q3 		$5.6M Sell
10,000
-5,000
-33% -$3.03M 2.41% 25
2020
Q2 		$9.36M Buy
15,000
+5,000
+50% +$2.84M 3.1% 10
2020
Q1 		$4.88M Sell
10,000
-10,000
-50% -$4.12M 1.93% 25
2019
Q4 		$7.51M Hold
20,000
– – 2.79% 13
2019
Q3 		$5.55M Hold
20,000
– – 2.8% 15
2019
Q2 		$6.26M Buy
20,000
+7,000
+54% +$2.33M 1.51% 11
2019
Q1 		$5.34M Buy
13,000
+3,000
+30% +$1.24M 1.97% 24
2018
Q4 		$3.73M Buy
+10,000
New +$3.66M 2.01% 25
2017
Q3 		– Sell
-10,000
Closed -$4.91M – 84
2017
Q2 		$4.91M Buy
+10,000
New +$4.38M 1.8% 22
2017
Q1 		– Sell
-17,500
Closed -$6.42M – 67
2016
Q4 		$6.42M Buy
17,500
+3,500
+25% +$1.33M 3.06% 13
2016
Q3 		$5.63M Buy
14,000
+4,000
+40% +$1.6M 2.84% 15
2016
Q2 		$3.49M Sell
10,000
-2,500
-20% -$963K 1.74% 29
2016
Q1 		$4.51M Buy
12,500
+7,500
+150% +$3.09M 1.99% 21
2015
Q4 		$2.71M Sell
5,000
-5,000
-50% -$2.71M 1.29% 38
2015
Q3 		$4.65M Buy
+10,000
New +$5.37M 2.26% 17
2014
Q2 		– Sell
-7,000
Closed -$2.1M – 77
2014
Q1 		$2.1M Buy
+7,000
New +$2.16M 1.31% 37

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Sivik Global Healthcare's REGN Position: Q2 2026 in Review

Sivik Global Healthcare held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 4,000 shares worth $3.09M. The position accounts for 2.35% of the portfolio, ranked #24.

Sivik Global Healthcare first reported a position in REGN in Q1 2014 and has held it in 20 quarters since. The position peaked at $9.66M in Q4 2020. 341 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Sivik Global Healthcare held 4,000 shares of Regeneron Pharmaceuticals worth $3.09M as of Q2 2026.
  • Sivik Global Healthcare left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 2.35% of Sivik Global Healthcare's portfolio in Q2 2026, its #24 holding.
  • Sivik Global Healthcare first reported a position in Regeneron Pharmaceuticals in Q1 2014 and has held it in 20 quarters since.
  • Sivik Global Healthcare's Regeneron Pharmaceuticals position peaked at $9.66M in Q4 2020.
  • 341 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.